Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
4 Stocks Under $10 to Trade for Big Breakouts
By Roberto Pedone
Sep 17, 2015 2:10 PM EDT
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of CorMedix Inc. - CRMD
By PR Newswire
Mar 18, 2021 4:49 PM EDT
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of CorMedix Inc. - CRMD
By PR Newswire
Mar 12, 2021 5:35 AM EST
PRESS RELEASES
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of CorMedix Inc. - CRMD
By PR Newswire
Mar 3, 2021 3:01 PM EST
PRESS RELEASES
CorMedix Receives Complete Response Letter From FDA For DefenCath™ Catheter Lock Solution
By GlobeNewswire
Mar 1, 2021 8:30 AM EST
PRESS RELEASES
CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting For New Drug Application For Defencath Is Not Needed
By GlobeNewswire
Nov 18, 2020 8:30 AM EST
PRESS RELEASES
CorMedix Appoints Greg Duncan To Its Board Of Directors
By GlobeNewswire
Nov 2, 2020 8:30 AM EST
PRESS RELEASES
CorMedix To Participate In BIO Investor Forum Digital
By GlobeNewswire
Oct 8, 2020 9:00 AM EDT
PRESS RELEASES
CorMedix Appoints Paulo Costa To Its Board Of Directors
By GlobeNewswire
Sep 17, 2020 8:30 AM EDT
PRESS RELEASES
CorMedix Inc. Announces FDA Acceptance For Filing And Priority Review Of New Drug Application For Defencath
By GlobeNewswire
Aug 31, 2020 7:47 AM EDT
PRESS RELEASES
CorMedix Announces Pricing Of $20M Public Offering Of Common Stock
By GlobeNewswire
Jul 28, 2020 9:21 AM EDT
PRESS RELEASES
CorMedix Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Jul 27, 2020 4:05 PM EDT
PRESS RELEASES
CorMedix Inc. Reports Submission Of Defencath™ New Drug Application
By GlobeNewswire
Jul 8, 2020 8:30 AM EDT
PRESS RELEASES
CorMedix Inc. Announces Appointment Of Chief Financial Officer
By GlobeNewswire
May 11, 2020 8:30 AM EDT
PRESS RELEASES
CorMedix Inc. Announces Contract Extension Of Jack Armstrong As Executive Vice President And Head Of Technical Operations
By GlobeNewswire
Apr 23, 2020 8:15 AM EDT
PRESS RELEASES
CorMedix Completes Sale Of $5.5 Million Of NOL Tax Benefits Through New Jersey Technology Business Tax Certificate Transfer Program
By GlobeNewswire
Apr 22, 2020 8:00 AM EDT
PRESS RELEASES
CorMedix Approved To Sell $5.5 Million Of NOL Tax Benefits Through The New Jersey Economic Development Authority Program
By GlobeNewswire
Feb 3, 2020 4:19 PM EST
PRESS RELEASES
CorMedix Inc. Announces FDA Grant Of Rolling Review Of Neutrolin® New Drug Application
By GlobeNewswire
Feb 3, 2020 8:15 AM EST
OPINION
4 Stocks Under $10 to Trade for Big Breakouts
By Roberto Pedone
Sep 17, 2015 2:10 PM EDT
OPINION
3 Stocks Under $10 Making Big Moves
By Roberto Pedone
Jul 30, 2015 2:49 PM EDT
MARKETS
Cormedix (CRMD): Today's Weak On High Volume Stock
By TheStreet Wire
Jun 30, 2015 10:02 AM EDT
STOCKS
Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!
By Adam Feuerstein
Jun 19, 2015 6:00 AM EDT
MARKETS
CorMedix (CRMD) Stock Gains After Receiving Positive FDA Feedback for Neutrolin
By Tony Owusu
Jun 17, 2015 12:38 PM EDT
MARKETS
Cormedix (CRMD): Today's Weak On High Volume Stock
By TheStreet Wire
Jun 12, 2015 10:01 AM EDT
MARKETS
Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock
By TheStreet Wire
Jun 5, 2015 10:02 AM EDT
